Andrew Witty articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2015/05/27 02:42
2015/05/27 02:42
3d
What fascinates me is how the heads of the world's biggest businesses lead their companies and deal with the personal and business pressures of being at the top. I have been a business journalist for...
2015/05/27 02:42
2015/05/27 02:42
Latest videos
2015/05/25 11:21
2015/05/25 11:21
5d
A combined Pfizer, based in New York City, and GSK, based in London, would be a staggering company indeed. Pfizer, the maker of drugs like Viagra and Celebrex, reports $50 billion in total sales and...
2015/05/16 00:41
2015/05/16 00:41
14d
Pfizer could have struck back with another bid, but AstraZeneca has made a decent fist of moving on. Sure, its sales targets have been set out so far in the distance that it will fall to chief...
2015/05/15 06:42
2015/05/15 06:42
15d
The success of a CEO is often predicated on the situational status of the company he or she inherits. Bill Steere took the helm at Pfizer in 1991, riding on the crest of five recently launched...
2015/05/14 06:37
2015/05/14 06:37
16d
UNC and GlaxoSmithKline pledge to cure AIDS The University and GSK created a new company and center. By Stephanie Lamm | Published 11 minutes ago Since 1981, when UNC Hospitals admitted its first...
2015/05/12 14:43
2015/05/12 14:43
17d
Kiran Mazumdar-Shaw, Chairperson of biopharmaceutical major Biocon Ltd, has been ranked No. 2 on 'The Medicine Maker Power List' 2015, an index of the 100 most influential people across the globe in...
2015/05/11 21:37
2015/05/11 21:37
18d
UNC, GSK create new company to cure HIV/AIDS Qura Therapeutics will be based on UNC's campus By Stephanie Lamm | Published 49 minutes ago UNC announced a partnership with leading pharmaceutical...
2015/05/11 04:49
2015/05/11 04:49
19d
GlaxoSmithKline PLC and the University of North Carolina at Chapel Hill are jointly launching a research center that will focus on one of the areas of most intense interest in HIV/AIDS science: the...
2015/05/08 18:37
2015/05/08 18:37
21d
While affluent countries such as the US fuel the industry, paying through the nose for the latest ‘blockbuster’ drugs for long-term conditions like asthma or high blood pressure, hundreds of thousands...
2015/05/07 20:23
2015/05/07 20:23
22d
Protesters hold up placards and a banner as Britain's Prime Minister David Cameron and his wife Samantha leave a polling station after voting in Spelsbury, central England, Britain. Photo by...
2015/05/07 16:50
2015/05/07 16:50
22d
The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. LONDON (Reuters) - GlaxoSmithKline's (GSK.L) new chairman Philip Hampton expressed support for the company's current...
2015/05/07 16:43
2015/05/07 16:43
22d
The British drugmaker scrapped a flotation of its HIV unit, ViiV, and slashed a cash payout by three-quarters to £1 billion. That's unfashionable in an era of spin-offs and shareholder returns -...
2015/05/07 11:56
2015/05/07 11:56
23d
Overnight Media Digest * Federal Reserve Chairwoman Janet Yellen weighed in on a growing debate among investors and market economists, suggesting the yearslong stock rally may have driven prices too...
2015/05/07 01:37
2015/05/07 01:37
23d
The chief executive Andrew Witty declared prospects for its HIV drugs arm had improved dramatically in the past few months, thanks to a rapid increase in sales and some new forms of medicine being on...
2015/05/06 16:56
2015/05/06 16:56
23d
LONDON: After relying for years on its top-selling lung drug Advair, GlaxoSmithKline is now braced for the worst in the form of cheap generics: but not just yet. Chief Executive Andrew Witty said on...
2015/05/06 12:15
2015/05/06 12:15
24d
GlaxoSmithKline laid out growth targets for its biggest businesses on Wednesday, hoping to convince investors that focusing on consumer health and vaccines would return the drugmaker to long-term...
2015/05/01 12:27
2015/05/01 12:27
29d
A British Airways airplane flies past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. LONDON (Reuters) - GlaxoSmithKline (GSK.L) may ditch a plan to return 4...
2015/05/27 02:42
2015/05/27 02:42
Latest from Twitter